Search research articles
Contact Us
Filters
Showing results (131-140 of 282) with videos related to
Page
of 29
Sort By:
Cancer Causes & Control : CCC
|
November 16, 2017
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study
Nathan P Papa, Robert J MacInnis, Dallas R English, et al.
European Urology
|
February 13, 2025
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
Arun A Azad, Louise Kostos, Neeraj Agarwal, et al.
BJU International
|
July 25, 2015
Patterns of care for metastatic renal cell carcinoma in Australia
Daphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes
Louise Emmett, Ur Metser, Glenn Bauman, et al.
Blood
|
November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
Max Schnurr, Qiyuan Chen, Amanda Shin, et al.
European Urology Focus
|
August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer
Heidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma
Ian D Davis, Birte K Skrumsager, Jonathan Cebon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2012
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans
Joe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
February 10, 2015
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
Oliver Klein, Ian D Davis, Grant A McArthur, et al.
Cancer Immunology, Immunotherapy : CII
|
February 21, 2008
IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma
Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A Freeman, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 282) with videos related to
Sort By:
Page
of 29
Cancer Causes & Control : CCC
|
November 16, 2017
Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study
Nathan P Papa, Robert J MacInnis, Dallas R English, et al.
European Urology
|
February 13, 2025
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
Arun A Azad, Louise Kostos, Neeraj Agarwal, et al.
BJU International
|
July 25, 2015
Patterns of care for metastatic renal cell carcinoma in Australia
Daphne Day, Yada Kanjanapan, Edmond Kwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2018
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes
Louise Emmett, Ur Metser, Glenn Bauman, et al.
Blood
|
November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
Max Schnurr, Qiyuan Chen, Amanda Shin, et al.
European Urology Focus
|
August 3, 2020
Prognostic Impact of Total Plasma Cell-free DNA Concentration in Androgen Receptor Pathway Inhibitor-treated Metastatic Castration-resistant Prostate Cancer
Heidi Fettke, Edmond M Kwan, Patricia Bukczynska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2007
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma
Ian D Davis, Birte K Skrumsager, Jonathan Cebon, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2012
Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans
Joe H Chang, Daryl Lim Joon, Sze Ting Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
February 10, 2015
Low-dose cyclophosphamide enhances antigen-specific CD4(+) T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
Oliver Klein, Ian D Davis, Grant A McArthur, et al.
Cancer Immunology, Immunotherapy : CII
|
February 21, 2008
IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma
Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A Freeman, et al.
Page
of 29